This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

proofread

Surgical sealing made better with robust thermosensitive bioadhesives

Surgical sealing made better with robust thermosensitive bioadhesives
Graphical abstract. Credit: Cell Reports Physical Science (2023). DOI: 10.1016/j.xcrp.2023.101259

As part of a collaborative effort, scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have employed inventive chemistry to produce an injectable biomaterial with significantly improved adhesive strength, stretchability, and toughness.

This chemically modified, gelatin-based hydrogel had attractive features, including rapid gelation at room temperature and tunable levels of adhesion. This custom-engineered biomaterial is ideal as a surgical wound sealant, with its controllable adhesion and injectability and its superior adherence to a variety of tissue and organ surfaces.

In order to provide closure for surgical wounds, the material must provide effective sealing on wet, slippery tissue surfaces, which vary in shape and could possibly involve tissue movement (an expanding lung, for example) or crumbly textures. The application and effectiveness of the sealant must also be within a suitable timeframe for surgical procedures.

Standard methods of suturing and stapling can be ineffective and time-consuming and can result in increased blood loss. Other methods using fibrin-based bioadhesive sealants are costly, exhibit insufficient adhesion, and can be prone to viral transmission.

Commercial gelatin-based wound dressings, although offering biocompatibility, low cost, and hemostatic effectiveness, lack adhesive strength due to inherent brittleness. Previous efforts to address poor adhesion problems have been made via functionalization with catechol, a naturally occurring compound that can impart adhesive capabilities when bound to gelatin. However, the small number of binding sites on the gelatin results in limited level of adhesion that can be enabled by catechol functionalization.

The researchers chose caffeic acid (CA), a catechol-containing compound found in coffee and , to increase the tissue adhesion efficacy of gelatin. They first oxidized CA to yield CA oligomers (CAO) which involve a small number of repeating catechol units. Coupling these CA derivatives to gelatin amplified chemical binding of catechol groups and boosted their adhesive function.

Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have employed inventive chemistry to produce an injectable biomaterial with significantly improved adhesive strength, stretchability, and toughness. It also features rapid gelation at room temperature and tunable levels of adhesion and injectability, giving it superior potential as a wound sealant for tissue and organ surfaces. Credit: Terasaki Institute for Biomedical Innovation

The engineered bioadhesive sealant had superior adhesive strength, stretchiness, toughness, and injectability, along with the ability for rapid gelation when applied to the wound site and showed stable adhesion in physiological conditions.

Furthermore, the sealants were designed to adhere to tissue in a selective manner. This is pivotal for an effective sealant, as there needs to be tight bonding at the sealant-tissue interface and non-binding on the opposite face of the sealant, which is exposed to the bodily environment.

Validation tests using the new sealant on wet collagen sheets, as well as burst pressure experiments to test the limits of its adhesive strength, demonstrated its effectiveness and proved contrary to previous reports of the detrimental effects of oxidative chemistry.

Experiments conducted on pig lung, heart, and bladder wounds showed that the new sealant had adhesive strength an order of magnitude higher than commercial gelatin-based sealants; the sealant also remained affixed to the tissue surface even after experimental scraping and twisting.

The new sealant was also shown to be . In addition, it was shown to have drug loading and drug release capabilities and could promote antioxidant effects beneficial to wound healing. This versatile strategy can be adapted as a powerful approach to impart strong to other biomaterials.

"Our team has utilized manipulative and strategic chemistry to significantly improve adhesive strength and versatility in biomaterials," said Ali Khademhosseini, TIBI's Director and CEO. "This creates exciting possibilities for more effective surgical wound management in the clinic."

The study is published in the journal Cell Reports Physical Science.

More information: Hossein Montazerian et al, Injectable gelatin-oligo-catechol conjugates for tough thermosensitive bioadhesion, Cell Reports Physical Science (2023). DOI: 10.1016/j.xcrp.2023.101259

Journal information: Cell Reports Physical Science
Provided by Terasaki Institute for Biomedical Innovation
Citation: Surgical sealing made better with robust thermosensitive bioadhesives (2023, March 29) retrieved 12 June 2024 from https://medicalxpress.com/news/2023-03-surgical-robust-thermosensitive-bioadhesives.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Team develops extracellular matrix-based sticky sealants for corneal tissue reconstruction

41 shares

Feedback to editors